BioArctic and Mesenkia enter oncology research collaboration

Summary

BioArctic and Mesenkia Therapeutics announced a research collaboration agreement to explore a novel antibody-based approach for glioblastoma treatment. The agreement establishes a partnership to advance early-stage oncology research in one of the most aggressive brain cancers.